All News

Edaravone has been approved for patients with amyotropic lateral sclerosis.

Antimicrobial susceptibility testing (AST) for newer antibiotics is falling behind because there is a lag time between FDA approval and inclusion in commercial AST devices.

High-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce the risk.

Dual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.

The risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.

What you need to know about the upcoming NCPA convention.

Pharmacists are uniquely poised to combat the opioid crisis. Here's what pharmacists (and Congress) can do about it.

When FluMIst was discontinued, there were worries that flu vaccination rates would drop.

From the Drug Topics archives, one of most popular features in our history returns.

Two pharmacists were charged in two different fraud cases.

Kiriko is recalling all lots of its weight-loss supplement.

A study finds that a significant number of FDA-mandated studies are unfinished.

Your Patients want to hear from you! Are you getting the word out?

The new ScriptPath Prescription Schedule system is expected to help patients and pharmacists.

A study commissioned by the NCPA shows the effect of DIR fees.

Proponents argue that limits reduce the risk of addiction, but are they keeping pharmacists from caring for their patients?

What you need to know about the latest new medications.

A pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.

Medical cannabis classes will no longer be held at the University of Maryland-Baltimore.

Is Amazon getting in on the PBM game?

Sometimes the people on top make your life miserable.

A worldwide operation shuts down hundreds of illegal websites.

The chain’s PBM will limit opioid prescriptions, along with a host of other opioid safety programs.

FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).

A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.

New data show that health benefit costs in 2018 will rise by their highest since 2011.

The pharmacy is launching its #ItEndsWithUs campaign to educate teens.

The pharmacy faces sanctions after nearly 1,000 IV bags were made with expired ingredients.